Base to Base biotech podcast 81: Breakthrough in shrinking tumours and restoring mitochondrial metabolism to address obesity
New bacteria discovered in DNA samples from prostate cancer patients
Estuary Biotherapeutics launches with $103m to develop gene therapies for kidney disease
Data show reduction in skin epigenetic age and systemic inflammatory biomarkers
Base to Base biotech podcast 5: Vitalant’s vital role in blood products, and Brainomix gives hope to stroke victims
Base to Base biotech podcast 4: A new class of therapeutics, and biotech hiring in 2025
Base to Base biotech podcast 3: Nanoparticles and Duchenne muscular dystrophy
Canadian university researchers discover new class of antibiotics
Base to Base biotech podcast 2: Opioid alternatives and epiproteomics
Base to Base biotech podcast 1: Osteoboost and Pheast Therapeutics
SXSW announces 2025 pitch competition finalists
LinkGevity secures place in SPACE-H accelerator programme